New era in virus testing at Canary Wharf
Between J.P. Morgan’s London headquarters and the Mastercard office in Canary Wharf lies an unassuming building that is home to some of the most transmissible viruses known to science. This
Between J.P. Morgan’s London headquarters and the Mastercard office in Canary Wharf lies an unassuming building that is home to some of the most transmissible viruses known to science. This
Healthcare company hVIVO, previously known as Open Orphan, anticipates reporting first-half revenues of £35.6m, marking a 30.6% increase compared to the same period last year. In a recent trading update
Clinical trials are essential for advancing medicine, enhancing drug discovery, and improving patient safety. There are two main types of clinical trials: observational and interventional. Understanding these types helps researchers
hVIVO’s CEO addressed the Canary Wharf group, discussing their world-leading title in human challenge trials and the company’s relocation to Canary Wharf. Yamin ‘Mo’ Khan emphasised hVIVO’s fit-for-purpose facility, featuring
Hvivo, a Dublin and London-listed pharmaceutical services company, reported a record revenue for the first half of the year, continuing its momentum in the market. Specialising in testing infectious and
hVIVO plc (LON:HVO), a fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has provided a trading update for the six-month
Clinical trials are a critical component of medical research, involving the testing of pharmaceutical drugs, medical devices, or other treatments on human participants to evaluate their efficacy and safety. These
The recent rise of the “tripledemic” – the simultaneous spread of the influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) – is posing significant risks, especially to older adults and
A recent study published in the journal Nature analyzed early cellular response dynamics to SARS-CoV-2 in seronegative individuals using single-cell multi-omics profiling, identifying key cellular states and immune responses associated
Highlights · hVIVO to enrol up to 1,000 healthy volunteers as part of a multicenter field study testing an influenza drug candidate, with hVIVO selected as the sole UK clinical site · Largest field